Robert Andrew Douglas - Apr 17, 2023 Form 4 Insider Report for RESMED INC (RMD)

Signature
Robert Douglas, President and Chief Operating Officer, ResMed Inc.
Stock symbol
RMD
Transactions as of
Apr 17, 2023
Transactions value $
-$336,975
Form type
4
Date filed
4/18/2023, 09:10 PM
Previous filing
Mar 16, 2023
Next filing
May 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale -$337K -1.5K -0.58% $224.65 257K Apr 17, 2023 Douglas Family Trust F1
holding RMD ResMed Common Stock 16.8K Apr 17, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan adopted February 9, 2023.